Microchip-based ultrafast serodiagnostic assay for tuberculosis

[1]  A. Rainoldi,et al.  Part II , 2012 .

[2]  J. Getty.  The problem of persistence , 2017 .

[3]  TUBERCULOSIS Diagnostics Technology and Market Landscape , 2015 .

[4]  Jaap M J den Toonder,et al.  Integrated lab-on-chip biosensing systems based on magnetic particle actuation--a comprehensive review. , 2014, Lab on a chip.

[5]  Utkan Demirci,et al.  Advances in Plasmonic Technologies for Point of Care Applications , 2014, Chemical reviews.

[6]  D. Beebe,et al.  The present and future role of microfluidics in biomedical research , 2014, Nature.

[7]  Francoise F Giguel,et al.  Micro-a-fluidics ELISA for Rapid CD4 Cell Count at the Point-of-Care , 2014, Scientific Reports.

[8]  James F Rusling,et al.  Nanomaterials and biomaterials in electrochemical arrays for protein detection. , 2014, Journal of materials chemistry. B.

[9]  P. MacAry,et al.  Novel phage display-derived mycolic acid-specific antibodies with potential for tuberculosis diagnosis[S] , 2013, Journal of Lipid Research.

[10]  D. Beebe,et al.  Automated Operation of Immiscible Filtration Assisted by Surface Tension (IFAST) Arrays for Streamlined Analyte Isolation , 2013, Journal of laboratory automation.

[11]  J. Rusling,et al.  Paper-based electrochemiluminescent screening for genotoxic activity in the environment. , 2013, Environmental science & technology.

[12]  Menno W J Prins,et al.  Magneto-capillary valve for integrated purification and enrichment of nucleic acids and proteins. , 2013, Lab on a chip.

[13]  Dhanuka P Wasalathanthri,et al.  Highly efficient binding of paramagnetic beads bioconjugated with 100,000 or more antibodies to protein-coated surfaces. , 2012, Analytical chemistry.

[14]  D. Boyle,et al.  Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries , 2012, Expert review of molecular diagnostics.

[15]  N. Engel,et al.  Point-of-Care Testing for Infectious Diseases: Diversity, Complexity, and Barriers in Low- And Middle-Income Countries , 2012, PLoS medicine.

[16]  Samuel K Sia,et al.  Commercialization of microfluidic point-of-care diagnostic devices. , 2012, Lab on a chip.

[17]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[18]  M. Pai,et al.  Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs. , 2012, Discovery medicine.

[19]  W. Qiu,et al.  Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care. , 2011, Lab on a chip.

[20]  James F Rusling,et al.  Magnetic particles in ultrasensitive biomarker protein measurements for cancer detection and monitoring. , 2011, Expert opinion on medical diagnostics.

[21]  N. Dendukuri,et al.  Commercial Serological Tests for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis: An Updated Systematic Review and Meta-Analysis , 2011, PLoS medicine.

[22]  Umut A. Gurkan,et al.  Enumeration of CD4+ T-Cells Using a Portable Microchip Count Platform in Tanzanian HIV-Infected Patients , 2011, PloS one.

[23]  Ruth McNerney,et al.  Towards a point-of-care test for active tuberculosis: obstacles and opportunities , 2011, Nature Reviews Microbiology.

[24]  Li-Ping Ye,et al.  Assessment of Five Antigens from Mycobacterium tuberculosis for Serodiagnosis of Tuberculosis , 2011, Clinical and Vaccine Immunology.

[25]  Umut A. Gurkan,et al.  Enumeration of CD 4 + T-Cells Using a Portable Microchip Count Platform in Tanzanian HIV-Infected Patients , 2011 .

[26]  Alimuddin Zumla,et al.  Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. , 2010, The Lancet. Infectious diseases.

[27]  Kunal Sur,et al.  Immiscible phase nucleic acid purification eliminates PCR inhibitors with a single pass of paramagnetic particles through a hydrophobic liquid. , 2010, The Journal of molecular diagnostics : JMD.

[28]  Philip L Felgner,et al.  Dynamic antibody responses to the Mycobacterium tuberculosis proteome , 2010, Proceedings of the National Academy of Sciences.

[29]  Martin A M Gijs,et al.  Microfluidic applications of magnetic particles for biological analysis and catalysis. , 2010, Chemical reviews.

[30]  Francisco Azuaje.  Biomarker‐Based Prediction Models: Design and Interpretation Principles , 2010 .

[31]  J. Lemaire,et al.  New diagnostics for tuberculosis: fulfilling patient needs first , 2010, Journal of the International AIDS Society.

[32]  Ali Khademhosseini,et al.  Integrating microfluidics and lensless imaging for point-of-care testing , 2009, 2009 IEEE 35th Annual Northeast Bioengineering Conference.

[33]  D. G. Siko,et al.  A novel application of affinity biosensor technology to detect antibodies to mycolic acid in tuberculosis patients. , 2008, Journal of immunological methods.

[34]  G. Bjune,et al.  A systematic review of delay in the diagnosis and treatment of tuberculosis , 2008, BMC public health.

[35]  Increased Synthesis of Anti-Tuberculous Glycolipid Immunoglobulin G (IgG) and IgA with Cavity Formation in Patients with Pulmonary Tuberculosis , 2008, Clinical and Vaccine Immunology.

[36]  Fengyan Luo,et al.  Clinical evaluation of the recombinant 38 kDa protein of Mycobacterium tuberculosis , 2008, Scandinavian journal of infectious diseases.

[37]  K. Steingart,et al.  Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review , 2007, PLoS medicine.

[38]  M. Perkins,et al.  Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. , 2006, The Lancet. Infectious diseases.

[39]  M. Gijs,et al.  Droplet-based DNA purification in a magnetic lab-on-a-chip. , 2006, Angewandte Chemie.

[40]  S. Kalantri,et al.  New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance , 2006, Expert review of molecular diagnostics.

[41]  R. Frei,et al.  Comparison of BacT/ALERT 3D, Lowenstein-Jensen medium and Middlebrook 7H10/7H11 biplate for recovering mycobacteria from clinical specimens , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[42]  J. Hayashi,et al.  Serum antibody response to tuberculosis-associated glycolipid antigen after BCG vaccination in adults , 2005, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[43]  Martin A. M. Gijs,et al.  Magnetic bead handling on-chip: new opportunities for analytical applications , 2004 .

[44]  Graham R. Stewart,et al.  Tuberculosis: a problem with persistence , 2003, Nature Reviews Microbiology.

[45]  E. Julián,et al.  Serodiagnosis of Tuberculosis: Comparison of Immunoglobulin A (IgA) Response to Sulfolipid I with IgG and IgM Responses to 2,3-Diacyltrehalose, 2,3,6-Triacyltrehalose, and Cord Factor Antigens , 2002, Journal of Clinical Microbiology.

[46]  I. Yano,et al.  Clinical Evaluation of Anti-Tuberculous Glycolipid Immunoglobulin G Antibody Assay for Rapid Serodiagnosis of Pulmonary Tuberculosis , 2001, Journal of Clinical Microbiology.

[47]  D. Min,et al.  Purification and Immunoreactivity of Three Components from the 30/32-Kilodalton Antigen 85 Complex inMycobacterium tuberculosis , 1999, Infection and Immunity.

[48]  Thomas Mattair,et al.  Obstacles and Opportunities , 1993 .

[49]  R. Müller,et al.  Fat emulsions for parenteral nutrition. I: Evaluation of microscopic and laser light scattering methods for the determination of the physical stability. , 1992, Clinical nutrition.

[50]  I. Yano,et al.  Rapid serodiagnosis of human mycobacteriosis by ELISA using cord factor (trehalose-6,6'-dimycolate) purified from Mycobacterium tuberculosis as antigen. , 1991, FEMS microbiology immunology.

[51]  R. Hunter,et al.  The role of surface in the biological activities of trehalose 6,6'-dimycolate. Surface properties and development of a model system. , 1981, The Journal of biological chemistry.